These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35900312)

  • 1. DIAGNOSIS OF ENDOCRINE DISEASE: Usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancer.
    Stewardson P; Eszlinger M; Paschke R
    Eur J Endocrinol; 2022 Sep; 187(3):R41-R52. PubMed ID: 35900312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL
    Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Triumvirate:: Correlating Thyroid Cytopathology, Molecular Testing, and Histopathology.
    Velez Torres JM; Tjendra Y; Kerr DA
    Surg Pathol Clin; 2023 Mar; 16(1):1-14. PubMed ID: 36739157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular testing for thyroid nodules: Review and current state.
    Roth MY; Witt RL; Steward DL
    Cancer; 2018 Mar; 124(5):888-898. PubMed ID: 29278433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Bias and Limitations of Clinical Validation Studies of Molecular Diagnostic Tests for Indeterminate Thyroid Nodules: Systematic Review and Meta-Analysis.
    DiGennaro C; Vahdatzad V; Jalali MS; Toumi A; Watson T; Gazelle GS; Mercaldo N; Lubitz CC
    Thyroid; 2022 Oct; 32(10):1144-1157. PubMed ID: 35999710
    [No Abstract]   [Full Text] [Related]  

  • 6. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role of molecular markers in the management of "indeterminate" thyroid nodules?
    Daniels GH
    Cancer Cytopathol; 2013 May; 121(5):223-4. PubMed ID: 23670834
    [No Abstract]   [Full Text] [Related]  

  • 9. [Next generation sequencing].
    Le Mercier M; D'Haene N; Rorive S; Degand C; De Nève N; Blanchard O; Salmon I
    Rev Med Brux; 2016; 37(5):436-438. PubMed ID: 28525213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Testing of Thyroid Nodules: A Review of Current Available Tests for Fine-Needle Aspiration Specimens.
    Zhang M; Lin O
    Arch Pathol Lab Med; 2016 Dec; 140(12):1338-1344. PubMed ID: 27557410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules.
    Nishino M; Nikiforova M
    Arch Pathol Lab Med; 2018 Apr; 142(4):446-457. PubMed ID: 29336606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the status of molecular testing for the indeterminate thyroid nodule and risk stratification of differentiated thyroid cancer.
    Nicholson KJ; Yip L
    Curr Opin Oncol; 2018 Jan; 30(1):8-15. PubMed ID: 29028645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Ancillary Techniques in Thyroid Cytology Specimens.
    Nishino M; Krane JF
    Acta Cytol; 2020; 64(1-2):40-51. PubMed ID: 30947167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidental thyroid nodule.
    Fisher SB; Perrier ND
    CA Cancer J Clin; 2018 Mar; 68(2):97-105. PubMed ID: 29369334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB?
    Ferraz C
    Arch Endocrinol Metab; 2018; 62(6):576-584. PubMed ID: 30624496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular diagnosis and management of thyroid neoplasms.
    Theoharis C; Roman S; Sosa JA
    Curr Opin Oncol; 2012 Jan; 24(1):35-41. PubMed ID: 22123232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine-needle aspirates: A quality-assurance metric for evaluating diagnostic performance in a cytopathology laboratory.
    Gokozan HN; Dilcher TL; Alperstein SA; Qiu Y; Mostyka M; Scognamiglio T; Solomon JP; Song W; Rennert H; Beg S; Stern E; Goyal A; Siddiqui MT; Heymann JJ
    Cancer Cytopathol; 2022 Apr; 130(4):259-274. PubMed ID: 34962713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of molecular testing of thyroid aspirates].
    Chijioke O
    Pathologe; 2022 Mar; 43(2):105-108. PubMed ID: 35013772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of thyroid nodule fine-needle aspiration cytology.
    Eszlinger M; Lau L; Ghaznavi S; Symonds C; Chandarana SP; Khalil M; Paschke R
    Nat Rev Endocrinol; 2017 Jul; 13(7):415-424. PubMed ID: 28361927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.